AGEP represents a drug-induced variant of generalized pustular psoriasis, enabling a unified therapeutic approach. Patients with higher-severity alopecia areata have a higher prevalence and incidence of comorbid atopic dermatitis. Early skin response predicts QOL gains in psoriasis, but some patients need tailored strategies despite skin clearance. Pembrolizumab effectively shrank or eliminated tumors for 90% of patients with unresectable advanced desmoplastic melanoma Standard-dose omalizumab and remibrutinib are among the most effective systemic treatments for chronic urticaria. The Genital Psoriasis Wellness Consortium issued consensus statements to help dermatologists better manage plaque psoriasis. Dermatologist Jennifer Cather, MD, shares best practices for conducting genital examinations for patients with psoriasis. Researchers called for efforts to address the clinical and psychological differences in early- versus late-onset psoriasis. Dr. April Armstrong explains the significance of having a benchmark to measure on-treatment remission in plaque psoriasis. A consensus group convened by the NPF determined a benchmark for on-treatment remission in plaque psoriasis. Interventions to enhance mucociliary activity may prevent infections of the nasal sinuses in patients with psoriasis. To determine prognosis for patients with melanoma, clinicians can access the free tool online at www.brainmetgpa.com. A survey-based study gauged patient adherence to their psoriasis biologic regimen based on dosing frequency schedule. Children with higher urinary levels of triclosan are more likely to develop eczema and allergic rhinitis, per research. Research suggests that the use of immune checkpoint inhibitors may double psoriasis risk for patients with cancer. Skin tone varied but overlapped among neonates, supporting pigment-based over race-based measures.
Researchers… The FamilyPso tool was created and validated to measure the burden of psoriasis on patients' partners. TUESDAY, July 15, 2025 (HealthDay News) -- Atopic dermatitis (AD) was associated with an increased risk for chronic kidney… TUESDAY, July 15, 2025 (HealthDay News) -- A high dietary inflammatory index (DII), which quantifies the inflammatory… Sonelokimab, lutikizumab, and adalimumab showed the highest HiSCR-50 response rates in moderate to severe HS, per a network ...